% | $
Quotes you view appear here for quick access.

Atossa Genetics, Inc. Message Board

  • zero.risk13 zero.risk13 Mar 4, 2014 11:19 AM Flag

    No Sweat, Switch to GTHP and This Fiasco Will Fade Into the Distant Past

    Hitch your wagon to the stock of the future.

    Over 60 million PAP smear tests are taken annually.
    GTHP developed a biophotonic cervical cancer scan that is noninvasive, more accurate and produces instant test results.

    The potential is huge!
    60M scans X $15 profit per disposable = $900M
    $19,000 per machine
    PLUS international sales

    Get in on the ground floor.

    The new CEO marketing whiz from GE Diagnostics and Abbott Healthcare will make GTHP a market leader.
    A $3M order was received from Turkey and dozens of distributors have been signed up.

    1 share of ATOS gets you 3 shares of GTHP.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.39+0.05(+15.56%)Apr 28 4:00 PMEDT